Laboratory Tested Products (115 Offers)
DRUG CLASS: AMYLIN ANALOG
ACTIVE SUBSTANCE: 10 MG CAGRILINTIDE ACETATE
FORM: 2 ML VIAL
ACTIVE HALF-LIFE: ~ 10 HOURS
DOSAGE: MEN 0.3-1.2 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: EPHITALON ACETATE
FORM: 2 ML VIAL x 50 MG
ACTIVE HALF-LIFE: ~ 4-6 HOURS
DOSAGE: MEN 5 MG-10 MG PER DAY
ACNE: NOT REPORTED
WATER RETENTION: MINIMAL
HIGH BLOOD PRESSURE (HBP): NO KNOWN IMPACT
HEPATOTOXICITY: NONE
AROMATIZATION: DOES NOT AROMATIZE
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: PEPTIDE HORMONE
ACTIVE SUBSTANCE: INSULIN-LIKE GROWTH FACTOR 1 LR3
FORM: 2 ML VIAL x 1 MG
ACTIVE HALF-LIFE: ~ 20–30 HOURS
DOSAGE: 20–100 MCG PER DAY
ACNE: NOT REPORTED
WATER RETENTION: LOW
HIGH BLOOD PRESSURE (HBP): NO KNOWN EFFECT
HEPATOTOXICITY: NONE
AROMATIZATION: DOES NOT AROMATIZE
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: PEPTIDE HORMONE
ACTIVE SUBSTANCE: IPAMORELIN
FORM: POWDER - 2 ML VIAL x 5 MG
ACTIVE HALF-LIFE: 2 HOURS
DOSAGE: MEN 200-300 MCG/DAY
ACNE: RARE
WATER RETENTION: MINIMAL
HIGH BLOOD PRESSURE (HBP): UNCOMMON
HEPATOTOXICITY: NONE REPORTED
AROMATIZATION: NONE
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
DUAL GLUCAGON AGONIST; GLP-1 AGONIST
ACTIVE SUBSTANCE: 10 MG MAZDUTIDE
FORM: 2 ML VIAL
ACTIVE HALF-LIFE: 158-180 HOURS
DOSAGE: MEN 3-9 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: PEPTIDE HORMONE
ACTIVE SUBSTANCE: MELANOTAN 2
FORM: POWDER - 2 ML VIAL x 10 MG
ACTIVE HALF-LIFE: ~ 30–36 HOURS
DOSAGE: 0.25–1 MG/DAY (LOADING), THEN 0.5–1 MG EVERY 2–3 DAYS (MAINTENANCE)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GIP/GLP-1/GLUCAGON RECEPTOR TRIAGONIST
ACTIVE SUBSTANCE: RETATRUTIDE
FORM: 2 ML VIAL x 10 MG
ACTIVE HALF-LIFE: ~ 6 DAYS
DOSAGE: 0.5 MG/WEEK
ACNE: N/A
WATER RETENTION: N/A
HIGH BLOOD PRESSURE (HBP): N/A
HEPATOTOXICITY: N/A
AROMATIZATION: N/A
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: NOOTROPIC PEPTIDE
ACTIVE SUBSTANCE: SELANK
FORM: POWDER - 2 ML VIAL x 10 MG
ACTIVE HALF-LIFE: ~ 2-3 HOURS
DOSAGE: MEN 250-500 MCG/DAY
ACNE: NO
WATER RETENTION: MINIMAL
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: SEMAGLUTIDE
FORM: LYOPHILIZED POWDER – 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: 0.25 - 0.5 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: NOOTROPIC PEPTIDE
ACTIVE SUBSTANCE: SEMAX
FORM: POWDER - 2 ML VIAL x 5 MG
ACTIVE HALF-LIFE: 2-3 HOURS
DOSAGE: MEN 200-600 MCG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
DUAL GLUCAGON AGONIST; GLP-1 AGONIST
ACTIVE SUBSTANCE: 10 MG SURVODUTIDE
FORM: 2 ML VIAL
ACTIVE HALF-LIFE: 109-115 HOURS
DOSAGE: MEN 0.6-4.8 MG/WEEK
ACNE: PERHAPS
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: THYMOSIN BETA-4
FORM: POWDER - 2 ML VIAL x 5 MG
ACTIVE HALF-LIFE: 2.5-3 DAYS
DOSAGE: MEN 7.66 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: PEPTIDE HORMONES
ACTIVE SUBSTANCES:
- 5 MG THYMOSIN BETA 4
- 5 MG PENTADECAPEPTIDE
FORM: 2 ML VIAL x 10 MG
ACTIVE HALF-LIFE: TB 500: 2-3 DAYS; BPC 157: 4-6 HOURS
DOSAGE: 2-6 MG PER WEEK
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: TIRZEPATIDE
FORM: LYOPHILIZED POWDER – 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~5 DAYS
DOSAGE: 2.5 - 5 MG/WEEK (RESEARCH USE ONLY)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: BETA-2 AGONIST, BRONCHODILATOR
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 TABLETS x 40 MCG
ACTIVE HALF-LIFE: 48-72 HOURS
DOSAGE: MEN 40-160 MCG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: BETA-2 AGONIST (FAT BURNER)
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 TABLETS × 40 MCG
ACTIVE HALF-LIFE: 36–48 HOURS
DOSAGE: MEN 120–140 MCG/DAY, WOMEN 80–100 MCG/DAY
ACNE: NO
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NONE
AROMATIZATION: NONE
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS
LABORATORY TESTED: VIEW LAB RESULTS
